IMMUPHARMA (LSE:IMM)

 

Latest News

FTSE surges as ECB unveils QE, financials rise

FTSE indices surged higher after European Central Bank unveiled a larger-than-expected bond-buying package of 60bn eu...

FTSE cautiously up as ECB's QE call nears

FTSE indices were cautiously firmer to midday on resources as the market looks to European Central Bank's (ECB) decisio...

Collaboration Agreement with Simbec-Orion

Statement regarding an alliance between entities

Holding(s) in Company

Notification of major interests in shares

All News

DateHeadlineSource
22-01-15FTSE surges as ECB unveils QE, financials riseStockMarketWire
22-01-15FTSE cautiously up as ECB's QE call nearsStockMarketWire
22-01-15Collaboration Agreement with Simbec-OrionRNS
30-10-14Holding(s) in CompanyRNS
28-10-14Holding(s) in CompanyRNS
21-10-14FTSE 100 makes strong recoveryStockMarketWire
21-10-14FTSE 100 bounces backStockMarketWire
21-10-14ImmuPharma raises £3.4m StockMarketWire
21-10-14Additional Listing - Conditional PlacingRNS
20-10-14ImmuPharma unit awarded €400,000 grant StockMarketWire
20-10-14ImmuPharma awarded EUR400,000 GrantRNS
30-09-14Losses remain at ImmuPharmaStockMarketWire
30-09-14Half Yearly ReportRNS
30-09-14LupuzorT Gears Up To Start Pivotal Phase III trialRNS
27-06-14Immupharma shareholders approve AGM resolutionsStockMarketWire
27-06-14Result of AGMRNS
27-06-14ImmuPharma extends research capabilitiesStockMarketWire
27-06-14Access to pioneering research in Bordeaux FranceRNS
16-06-14ImmuPharma granted new Nucant patents StockMarketWire
16-06-14NEW NUCANT PATENTSRNS
23-05-14Annual Financial ReportRNS
21-05-14ImmuPharma pre-tax losses riseStockMarketWire
21-05-14Preliminary ResultsRNS
06-05-14ImmuPharma gives summary from lupus conference StockMarketWire
06-05-14Dr. Sylviane Muller - Presentation AbstractRNS
23-04-14Lupuzor founder presents at Osaka UniversityStockMarketWire
23-04-14Dr. S Muller, founder of Lupuzor presentation.RNS
11-04-14ImmuPharma Sponsors the 2014 European Lupus ConferRNS
14-10-13Additional ListingRNS
27-09-13ImmuPharma trims operating lossStockMarketWire
27-09-13Half Yearly ReportRNS
13-08-13ImmuPharma gives update on cancer programmeStockMarketWire
13-08-13UPDATE CANCER PROGRAMME IPP-204106RNS
31-07-13FDA GRANTS IMMUPHARMA AMENDED SPARNS
08-07-13ImmuPharma appoints opinion leaders to advisory board StockMarketWire
08-07-13ImmuPharma appoints opinion leaders to advisory board StockMarketWire
08-07-13IMMUPHARMA APPOINTS WORLDWIDE KEY OPINION LEADERSRNS
05-06-13Holding(s) in CompanyRNS
23-05-13Result of AGMRNS
21-05-13ImmuPharma agrees £50 financingStockMarketWire

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory